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Abstract
Background
There is a worldwide upscale in mass drug administration (MDA) programs to control the
morbidity caused by soil-transmitted helminths (STHs): Ascaris lumbricoides, Trichuris tri-
chiura and hookworm. Although anthelminthic drugs which are used for MDA are supplied
by two pharmaceutical companies through donation, there is a wide range of brands avail-
able on local markets for which the efficacy against STHs and quality remain poorly
explored. In the present study, we evaluated the drug efficacy and quality of two albenda-
zole brands (Bendex and Ovis) available on the local market in Ethiopia.
Methodology/Principal Findings
A randomized clinical trial was conducted according to the World Health Organization
(WHO) guidelines to assess drug efficacy, by means of egg reduction rate (ERR), of
Bendex and Ovis against STH infections in school children in Jimma, Ethiopia. In addition,
the chemical and physicochemical quality of the drugs was assessed according to the
United States and European Pharmacopoeia, encompassing mass uniformity of the tablets,
amount of active compound and dissolution profile. Both drugs were highly efficacious
against A. lumbricoides (>97%), but showed poor efficacy against T. trichiura (~20%). For
hookworms, Ovis was significantly (p < 0.05) more efficacious compared to Bendex (98.1%
vs. 88.7%). Assessment of the physicochemical quality of the drugs revealed a significant
difference in dissolution profile, with Bendex having a slower dissolution than Ovis.
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Conclusion/Significance
The study revealed that differences in efficacy between the two brands of albendazole
(ABZ) tablets against hookworm are linked to the differences in the in-vitro drug release pro-
file. Differences in uptake and metabolism of this benzimidazole drug among different hel-
minth species may explain that this efficacy difference was only observed in hookworms
and not in the two other species. The results of the present study underscore the importance
of assessing the chemical and physicochemical quality of drugs before conducting efficacy
assessment in any clinical trials to ensure appropriate therapeutic efficacy and to exclude
poor drug quality as a factor of reduced drug efficacy other than anthelminthic resistance.
Overall, this paper demonstrates that “all medicines are not created equal”.
Author Summary
Soil-transmitted helminths (STHs) infect millions of children worldwide. To fight STH,
large-scale de-worming programs are implemented in which anthelmintic drugs (either
albendazole (ABZ) or mebendazole (MEB)) are administered. However, there is a wide
range of other brands, which are even more accessible, but for which the efficacy and qual-
ity remain poorly explored. We evaluated efficacy against STHs and quality of two ABZ
brands commonly available on the local markets in Ethiopia (Bendex and Ovis). Both
brands showed high efficacy against roundworm infections and poor efficacy against
whipworms. However, for hookworm infections, Bendex was significantly less efficacious
than Ovis. In terms of drug quality, a significant difference was observed in the dissolution
profile, with Bendex having a significantly slower dissolution rate than Ovis. Since dissolu-
tion behavior is critical for a drug to be appropriately absorbed into the helminth (through
host-blood and/or parasite-cuticle) and produce therapeutic efficacy, the poor dissolution
of Bendex compared to Ovis can explain the observed difference in efficacy against hook-
worms. Our results emphasize the importance of periodically assessing of drug quality to
ensure appropriate therapeutic efficacy and to exclude poor drug quality as a potential fac-
tor of reduced drug efficacy other than drug resistance.
Introduction
Currently, there is a worldwide upscale in the implementation of programs to control and to
eliminate a selection of 10 neglected tropical diseases [1, 2]. Among these, soil-transmitted hel-
minthiasis causes the highest burden on public health. It is estimated that more than 1.4 billion
people were infected with at least one of the four STH species: the roundworm Ascaris lumbri-
coides, the whipworm Trichuris trichiura and the two hookworm species Necator americanus
and Ancylostoma duodenale, resulting in a global burden of approximately 5.2 million disabil-
ity-adjusted life years (DALYs) (20% of the total number of DALYs attributable to neglected
tropical diseases) [3, 4]. To control the morbidity caused by STH, mass drug administration
(MDA) of a single oral dose of a benzimidazole anthelminthic drug (ABZ or MEB) is recom-
mended in communities where the prevalence of any STH exceeds 20% [5].
To date, major pharmaceutical companies such as GlaxoSmithKline (ABZ, Zentel) and
Johnson and Johnson (MEB, Vermox) are donating these medicines to WHO, which subse-
quently distribute these medicines to its recipient countries. In Ethiopia, the donated medicines
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are made available for the patients through government hospitals and health centers. The ther-
apeutic efficacy of these products at the WHO-recommended dosages (i.e. single dose of 400
mg ABZ or 500 mg MEB) has recently been evaluated in two consecutive multinational trials
[6, 7]. These trials showed that the therapeutic efficacy measured in terms of egg reduction rate
(ERR), varied both between drugs and STH species: both drugs showing high efficacy against
A. lumbricoides (> 98%) and poor efficacy against T. trichiura (~64%), and ABZ being more
efficacious against hookworms compared to mebendazole (96% vs. 80%). In addition to these
two donated brands, there is a wide range of other brands available on local markets of STH
endemic countries, which are often more accessible to the local people, but for which the effi-
cacy or quality remain poorly explored [8]. The latter is particularly important in countries
where resources are limited to monitor the quality of drugs, and hence in which prevalence of
substandard, falsified or illegal drugs is substantial [9–14]. Although the quality of medicines
has a direct influence on therapeutic efficacy, this remains poorly studied for benzimidazole
anthelminthic drugs against STH infections. Therefore, we assessed both the efficacy and qual-
ity of two brands of ABZ commonly administered for the treatment of individual STHs in Ethi-
opia, namely Bendex and Ovis.
Methods
Ethical statement
The study protocol was approved by the Ethical Committees of Jimma University (Ethiopia)
(reference no RPGC/282/2014) and of the Faculty of Medicine, Ghent University (Belgium)
(ref. no 2013/1114; B670201319330). The study is registered under clinicaltrial.gov identifier
number NCT02420574 (https://clinicaltrials.gov/ct2/show/NCT02420574?term=
NCT02420574&rank=1). The school authorities, teachers, parents, and the children were
informed about the purpose and procedures of the study. The written consent form was pre-
pared in two commonly used local languages (Afaan Oromo and Amharic) and handed over to
the children’s parents/guardians after explaining the aim, confidentiality and entire procedure
of the clinical trial. Only those children (i) who were willing to participate and (ii) whose
parents or guardians signed the written informed consent form were included in the study.
Moreover, an additional separate written informed consent form for children older than 12
years was prepared, read and handed over to them and their additional written informed con-
sent obtained (S1 Checklist).
Origin of the drugs
Samples of the two ABZ brands (Bendex, India, CIPLA Ltd, batch no: x21253 and Ovis, Korea,
DaeHWa Pharmaceuticals, batch no: 2020) with a label claim of 400 mg/tablet and expiry date
of November 2015 were purchased from private community pharmacy in Jimma town,
Ethiopia.
Assessment of therapeutic efficacy against STH infections in school
children
Study site and study population. The study was conducted in Jimma town, Ethiopia,
which is located approximately 350 km southwest of the capital Addis Ababa. This study
focused on school children (aged 5 to 18 years) from 2 out of the 24 primary schools that are
found in Jimma Town. These schools were selected based on previous STH prevalence data
[15, 16] and their involvement in previous drug efficacy trials [6, 7, 17]. At the time of this trial,
these schools were not included in any MDA program.
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Study design. The initial objective of this study was to assess the efficacy of ALB medicines
against STH infections in school children. To this end, we applied the recently published
WHO guidelines on the efficacy assessment of anthelminthic drugs against Schistosomiasis
and STH to evaluate the efficacy of both brands [5]. In this guideline, at least 50 infected sub-
jects per STH species are required. We also evaluated the quality of both medicines. Hence, this
survey was originally not designed to assess a difference in ERR between brands, but merely to
verify whether drugs were satisfactory, doubtful or unsatisfactory. Hence, no a prior power cal-
culation was performed, but the results were repeated together with the 95% CI and p-value (at
significant level of 5%). In short, parents/guardians were informed about the aims and the pro-
cedures of the entire clinical trial. Based on this, school children were recruited on a voluntary
basis and asked to provide a stool sample during a pre-intervention survey. Among these,
infected children who fulfill the WHO criteria for efficacy trial were enrolled for intervention.
For the initial sampling, the aim was to enroll at least 100 infected children (50 for each ABZ
brand) for A. lumbricoides, T. trichiura and hookworm, separately. Subjects with multiple
infections were subsequently randomized across the two ABZ brands, stratifying for mono,
double and triple STH infections. The drugs were administered under the direct supervision of
a clinical nurse. Fourteen days after drug administration, stool samples were again collected
from the subjects. All stool samples were processed by the McMaster egg counting method
[18]. A tutorial on how to perform the McMaster egg counting method can be found at http://
www.youtube.com/watch?v=UZ8tzswA3tc. Subjects who were unable to provide a stool sample
at follow-up, or who were experiencing a severe intercurrent medical condition (any medical
conditions other than parasitic infection) or had diarrhea at the time of the first sampling, were
excluded from the study. The flowchart summarizing the number of subjects recruited,
enrolled, lost at follow-up and included in the statistical analysis is presented in Fig 1, bearing
in mind that individual children may have double infections.
Assessment of drug quality
The quality of the drugs was evaluated by investigating three efficacy-critical quality attributes:
(i) the mass uniformity, (ii) the amount of the active compound, and (iii) the dissolution of the
tablets.
Drugs/reagents/chemicals/solvents. ABZ USP reference standard (Greenfield Pharma-
ceuticals, batch number: 20070504), Sulfuric acid AR (reagent chemicals service Ltd, United
Kingdom), ammonium phosphate monobasic (extra pure, Cisco Research laboratory Pvt. Ltd.,
India), hydrochloric acid (36% w/v, Fisher Chemicals, Germany), sodium hydroxide (BDH
Laboratory supplies, England), HPLC grade methanol and acetonitrile (CARLO ERBA
Reagents, England) and ultrapure HPLC water (18.2 MO cm resistivity) were used.
Mass uniformity. Twenty tablets of each brand were randomly selected and individually
weighed with a calibrated balance (Metter Toledo, AL204-1C, Switzerland) with experimen-
tally determined operating range of 94.63 mg to 200 g and accuracy of 0.006% [19]. This mass
uniformity between tablets of each brand was evaluated against the European pharmacopoeia
specification [20].
Amount of active compound. The assay of the active pharmaceutical ingredient (API)
was performed by a validated reversed-phase method according to USP [21], using an Agilent
1260 HPLC system equipped with an Agilent ZORBAX SB-18 column (150 x 4.6 mm, 5 μm)
and UV-VIS Diode Array Detector. The detection wavelength, column temperature, flow rate
of the mobile phase and injection volume were set at 254 nm, 25°C, 1 ml/min and 20 μl, respec-
tively. The isocratic mobile phase used was composed of methanol and 0.05 M phosphate
buffer (pH 5.5) (60:40% v/v). The analytical method was validated according to International
Efficacy and Quality of Albendazole Tablets
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Fig 1. The number of subjects recruited, enrolled, and lost at follow-up in a two-armed efficacy trial.
doi:10.1371/journal.pntd.0004057.g001
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Conference on Harmonisation (ICH) Q2(R1) recommendation [22]. The linearity of the
method was evaluated around the target label claim concentration (analytical aliquot concen-
tration of 200 μg/ml) ranging from 160 to 240 μg/ml ABZ. The regression line was assessed by
determining the 95% confidence interval (95% CI) of slope and intercept parameters as well as
by evaluating the residual plot. Repeatability precision was evaluated by injecting six replicates
of 100% test concentration (200 μg/mL) and percent relative standard deviation (%RSD) of the
measurements was calculated. The accuracy and range of the method was determined by spike
experiments at five different concentrations corresponding to 80, 90, 100, 110 and 120% of the
nominal analytical concentration (200 μg/ml).
System suitability was evaluated by (1) the symmetry factor (As) of the ABZ reference stan-
dard, calculated using the European Pharmacopoeia (Ph. Eur.) equation As = w0.05 / 2d, where,
w0.05 is the width of the peak at one twentieth of the peak height and d is the distance between
the perpendicular dropped from the peak maximum and the leading edge of the peak at one
twentienth of the peak height; and (2) injection repeatability by injecting (6 times) the ABZ ref-
erence standard solution. The Ph.Eur. system suitability test (SST) specifications were consid-
ered, i.e. As maximally 1.5 and percentage relative standard deviation (%RSD) maximally 0.85
[23].
Dissolution profile. The dissolution of both brands was evaluated using a dissolution
apparatus II (paddle) (RC-6D Tian Jin optical instruments, China) following United States
Pharmacopoeia recommendation [21]. The dissolution medium (900 mL 0.1 N HCl) was
transferred to vessels of dissolution apparatus and the temperature and the spindle rotation
speed were set to 37 ± 0.5°C and 50 rpm, respectively. Three tablets from each brand were ran-
domly assigned to the six dissolution vessels and 10.0 ml samples were withdrawn at predeter-
mined time points (0, 15, 30, 35, 40, 45 min) and replenished with an equal volume of fresh
dissolution medium at the same temperature. The samples were immediately filtered using
Whatman No. 1 filter paper and suitably diluted in 250 mL volumetric flask with 0.1 N sodium
hydroxide. The absorbance of each sample was determined at 308 nm and 350 nm using a UV/
Visible spectrophotometer (Aquarius, Cambridge, England) and the difference taken as absor-
bance value. A 0.1 N sodium hydroxide was used as the blank solution. The quantity in milli-
gram (mg) of ABZ dissolved was calculated by the formula 22.5C(Au/As), where C is the
concentration of ABZ reference standard (RS) in the standard solution (μg per mL) and Au and
As are the absorbance differences, obtained at 308 nm and 350 nm, of the solution under test
(Au) and the standard solution (As). This method was also validated according to ICH Q2(R1)
recommendations, for linearity, precision and accuracy [22]. In order to clarify one of the pos-
sible reasons to explain the different dissolution behavior, IR spectra of both tablets were
recorded on a qualified FTIR spectrometer (Thermo Scientific, USA), using the KBr-disk
methodology as described in the Ph. Eur. [24].
Statistical analysis
Assessment of drug efficacy. The efficacy of each ABZ brand was reported for each of
three STH species by means of ERR, using the formula below:
ERR ð%Þ ¼ 100% arithmetic mean ðFEC at baselineÞ arithmetic mean ðFEC at follow upÞ
arithmetic mean ðFEC at baselineÞ
 
Based on the obtained ERR results, the efficacy of the brands were classified as ‘satisfactory’,
‘doubtful’ and ‘reduced’. The criteria applied for this classification were suggested by WHO [5]
and are summarized in Table 1. The 95% confidence intervals (95% CI) for age, sex ratio and
FEC at baseline, and ERR were determined by bootstrap analysis (10,000 iterations).
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Permutation tests were performed to verify differences between both groups [25]. These per-
mutation tests consisted of 2 consecutive steps. First, the permutation distribution under the
null hypothesis that in average there was no difference in age, sex ratio, and FEC at baseline,
and ERR between two treatment arms was generated. To this end, all individuals of both arms
were randomly re-assigned to one of the treatment arms (the number of individuals in each
treatment arm remained unchanged). The new mean age, sex ratio, FEC and ERR for each of
the two treatment arms was determined and the absolute value of the difference in age, sex
ratio, FEC and ERR between treatment arms was calculated. Next, this procedure was repeated
10,000 times. The distribution of these 10,000 permutated age, sex ratio, FEC and ERR differ-
ences represented the permutation distribution when the null hypothesis is true. Second, the
probability of finding a value as extreme as the absolute value of the observed difference in age,
sex ratio, FEC and ERR between the two treatment arms in this permutation distribution was
determined. The level of significance was set at p< 0.05.
Assessment of drug quality
Mass uniformity. The uniformity of mass between tablets of each brand was evaluated
against Pharmacopoeial specification limit.
Amount of active compound. The appropriateness of the model was assessed by deter-
mining the 95% confidence interval (95% CI) of slope and intercept parameters of regression
line as well as by evaluating the residual plot. The amount of active compound of the two
brands were evaluated against Pharmacopoeial specification limit.
Dissolution profile. Data of the dissolution profile of the two brands were compared
using various mathematical models, t-test and model independent approaches (difference fac-
tor (f1), similarity factor (f2) and dissolution efficiency (DE)). KinetDS software program was
used to determine dissolution efficiency (DE) or the area under a dissolution curve between
defined time points and the best fit model for the dissolution profile of both brands. Measures
of goodness of fit (Akaike Information Criterion (AIC) and determination coefficient (r2))
were used to determine the performance of dissolution models.
Results
Assessment of drug efficacy
In total, 679 subjects were recruited of which 418 subjects were enrolled and randomized across
the two brands of ABZ (nBendex = nOvis = 209). T. trichiura was the most prevalent (69.4%), fol-
lowed by A. lumbricoides (53.6%). Hookworm infections were found in 28.2% of the subjects.
In total 388 subjects completed the trial (nBendex = 197; nOvis = 191), resulting in a compliance
rate of more than 90%. There was no significant difference in mean age (Bendex: 10.3 years vs.
Ovis: 10.3 years, p = 1.00), sex ratio (Bendex: 1.07 vs. Ovis: 0.87, p = 1.00) and mean fecal egg
count (FEC) (A. lumbricoides: Bendex: 8,706 egg per gram of feces (EPG) vs. Ovis: 7,935,
p = 0.69; T. trichiura: Bendex: 909 EPG vs. Ovis: 769, p = 0.45; hookworm: Bendex: 355 EPG vs.
Ovis: 335, p = 0.79) between the two arms at baseline. Both brands showed high efficacy against
Table 1. The criteria byWHO recommended to classify the efficacy of albendazole against soil-transmitted helminths.
Criteria A. lumbricoides T. trichiura Hookworm
Satisfactory ERR  95% ERR  50% ERR  90%
Doubtful 95% > ERR  85% 50% > ERR  40% 90% > ERR  80%
Reduced ERR < 85% ERR < 40% ERR < 80%
doi:10.1371/journal.pntd.0004057.t001
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A. lumbricoides (Bendex: 98.7% vs. Ovis: 97.8%, p = 0.64), and poor efficacy against T. trichiura
(Bendex: 24.4% vs. Ovis: 20.4%, p = 0.81). For hookworm infections, Ovis was more efficacious
than Bendex, though the difference was marginally significant (Bendex: 88.7% vs. Ovis: 98.1%,
p = 0.05). Based on the WHO criteria to classify the efficacy of anthelminthic drugs (Table 1),
both brands had satisfactory and reduced efficacy against A. lumbricoides and T. trichiura,
respectively. For hookworms, Ovis had a satisfactory efficacy, whereas Bendex had a doubtful
efficacy. A pairwise comparison of baseline parameters and drug efficacy between Bendex and
Ovis are presented in S1 Table.
Assessment of drug quality
Mass uniformity. The results of mass uniformity of ABZ tablets of each brand are pre-
sented in Table 2. The results revealed that both brands of ABZ tablets complied with pharma-
copoeial specification limit [20].
Amount of active compound. Method validation results indicated the fitness-for-use of
the applied HPLC method. The 95% CI for the regression slope equaled 20.47 (95% CI: 20.14
to 20.80) and y-intercept equaled 9.99 (95% CI: -57.44 to 77.41) together with r2 value of 0.999
and ANOVA F-value of 17,551 proved a strong positive linear relationship. In addition, ran-
dom pattern of the residual plot showed a good fit of the linear model to the data. The %RSD
(0.26) for repeatability of the method was within the specification limit (%RSD 0.85). The
results of percent recovery (mean % ± %RSD = 99.59 ± 0.57% to 100.42 ± 0.11%) were within
acceptable range. The comparative assay results of the two brands of albendazole tablets are
presented in Table 2: no significant difference at 95% CI (p 0.05) was found. Both brands
were found to be complying with the acceptance criteria for assay of ABZ tablets [21] i.e. 90–
110% label claim.
Dissolution profile. The applied method was linear over concentrations ranging from 5
to 15 μg/ml of ABZ. The slope equaled 0.05 (95% CI: 0.04 to 0.05) and intercept equaled 0.02
(95% CI: -0.001 to 0.023) showed linear association between the UV-signal and concentration.
In addition, the residual plot indicated a good fit of linear regression. The %RSD for repeatabil-
ity of the method was 0.01%. The ABZ recovery (mean % ± %RSD) of this method ranged
from 98.64 ± 0.00% to 103.18 ± 0.0.01%. The comparative in-vitro dissolution results of the
two brands of ABZ tablets are presented in Fig 2.
A single-point comparison (amount of dissolved active pharmaceutical ingredient (Q) in 30
minutes) of the two brands of ABZ tablets indicated that Bendex released 20.1%, while Ovis
released 84.9%. While Ovis complied with the acceptance criteria of United States Pharmaco-
poeia (USP) monograph, Bendex failed [21]. The release profile between Bendex and Ovis was
significantly (p = 0.002) different, as quantitatively expressed by the values of similarity factor
(f2) and difference factor (f1) between the two brands being 11 and 74, respectively. The disso-
lution efficiency (DE) of Bendex (15.83) was lower than the corresponding value observed for
Ovis (63.48). The infra-red (IR) spectra of Bendex and Ovis are presented in Figs 3 and 4.
IR spectra of both brands showed no significant difference between the two brands, suggest-
ing the similarity in solid state polymorphic form of ABZ in both brands. The IR spectrum of
Table 2. Results of weight and API-assay of albendazole tablet brands (Bendex and Ovis).
# Product Batch no. Expiry Date Pack Weight (mg; mean ± SD) (n = 20) Assay (%lc; mean ± SD) (n = 6)
1 Bendex 21253 Nov, 2015 Box of 1x100 tablets 1175.6 ± 4.90 99.10 ± 0.70
2 Ovis 2020 Nov, 2015 Box of 10x10 tablets 696.7 ± 0.02 99.40 ± 1.30
lc: label claim
doi:10.1371/journal.pntd.0004057.t002
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the major excipient of Ovis (i.e. anhydrous dibasic calcium phosphate) did not interfere with
the ABZ spectrum, while the excipients with interfering IR spectrum (i.e. sodium lauryl sulfate:
2957 and 2918 cm-1 and magnesium stearate: 2918 cm-1) were only present at much lower con-
centrations than ABZ in the Ovis tablet, hence neglecting their IR interference. Finally, the
release kinetics of ABZ from both brands was evaluated using mathematical modeling. The
results of measures of goodness of fit (i.e. AIC and r2) for different dissolution models are pre-
sented in S2 Table. The model that best fitted the dissolution data of both brands was Weibull
with lag time: the fact that both brands best fitted the data is indicative for a similar release
mechanism of albendazole from the tablets.
Discussion
Assessing the quality and in-vivo efficacy differences between different brands of ABZ tablets
are very critical to avoid indiscriminate use of different brands that could influence intended
therapeutic outcomes. In the present study, we evaluated comparative in-vivo efficacy and in-
vitro quality of two commonly available brands of ABZ tablets (Bendex and Ovis) that are used
to treat STH infection.
The in-vivo efficacy results of two brands of ABZ against A. lumbricoides and T. trichiura
determined in terms of ERR, suggest the susceptibility difference between the two STHs. Ther-
apeutic efficacy of antihelmnthics can be influenced by various factors such as infection inten-
sity and susceptibility of parasites. Thus the reduced efficacy of both brands against T. trichiura
Fig 2. Dissolution profile (mean ± SD, n = 6) of Bendex and Ovis in 0.1 N HCl (900 ml) using USP II
apparatus.
doi:10.1371/journal.pntd.0004057.g002
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observed in the present study could be due to high level of infection intensity [17] and/or
genetic modification of beta-tubulin gene [26, 27]. Since concentration of API at the target site
of the parasites could be low due to metabolism and/or limited absorption of the drug by the
parasite [28, 29], the reduced efficacy of both brands against T. trichiuramight also be associ-
ated with the pharmacokinetics of ABZ in the parasite. The reduced efficacy of the two brands
against T. trichiura observed in the present study is comparable to the results reported in the
previous studies [6, 17]. The present finding, i.e. high prevalence of T. trichiura among other
STHs in the study area together with the reduced efficacy results in ERR observed for single
dose of ABZ 400 mg tablets, is supported by various literature findings [30–33]. This empha-
sizes the urgent need for alternative drugs and/or development of novel anthelmintic drugs to
tackle this efficacy problem.
Medicines quality is a critical factor that could affect efficacy of drugs against parasites [34]
and for biopharmaceutical classification system (BCS) class II [35] drugs like ABZ that have
low solubility and high permeability, dissolution is the rate-limiting step for drug absorption.
Hence, in-vivo/in-vitro correlation between blood concentration profile and dissolution profile
may be expected. Since the bioavailability of ABZ to the host is very low and also shows vari-
ability between individuals [36], a decreased dissolution could significantly worsen bioavail-
ability, which in turn diminishes in-vivo efficacy of both the parent drug and therapeutically
active metabolite (ABZ sulphoxide). Moreover, the capacity of anthelminthics to dissolve
appropriately is an essential characteristic that allows proper drug uptake by the parasites and
therefore assures the appropriate drug efficacy. Therefore, the four times decreased dissolution of
Bendex compared to Ovis (Fig 2) which could influence both local and systemic concentration is a
Fig 3. Infra-red spectra of Bendex.
doi:10.1371/journal.pntd.0004057.g003
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plausible explanation for the efficacy difference between the two brands against hookworms,
which are blood sucking parasites. Previous studies already indicated the differences in uptake and
metabolism of benzimidazole drugs among different helminth species [28, 29], which may explain
that the efficacy difference between the two brands was only observed against hookworms.
Though mass uniformity and content of API per tablet are critical quality attributes that
could influence efficacy, comparable quality of both brands with respect to mass uniformity
and ABZ content observed in the present study (Table 2) explain the efficacy difference
between the two brands against hookworms is not associated with mass uniformity and con-
tent of API.
Considering a single point dissolution specification for ABZ tablets as described in the USP,
i.e. Q 80% dissolved in 30 min [22], there is a statistically significant (p 0.05) difference
Fig 4. Infra-red spectra of Ovis.
doi:10.1371/journal.pntd.0004057.g004
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observed between Bendex (Q = 20%) and Ovis (Q = 85%) (Fig 2). Also, the area under the dis-
solution curve between defined time points (0, 15, 30, 45 min) or DE quantifies the poor in-
vitro dissolution of Bendex. While Ovis thus complied to the USP dissolution specifications,
Bendex on the contrary did not. Although an undesirable polymorphic solid state of albenda-
zole could be one of the reasons for the difference in dissolution behavior of API [37–39], the
IR spectra (Figs 3 and 4) of Bendex and Ovis showed no significant difference between the two
brands. The absence of significant observed shifts in IR-absorption indicates the similarity in
polymorphic form of ABZ in both brands. Thus, the significant difference in dissolution
observed between the two brands could not be associated with different polymorphic forms of
ABZ. Whatever the reason of dissolution difference is, e.g. excipient and processing
manufacturing conditions and stability, the poor dissolution behavior of Bendex observed in
the present study is in accordance with the previous reports in which 41 samples out of 72 sam-
ples of solid oral dosage forms including ABZ tablets, different generic formulations of alben-
dazole tablets and carbamazepine immediate-release products did not comply with the
established acceptance criteria [40–42]. In general, it is important to note that quality of medi-
cines could be one of the factors influencing outcomes of clinical trials. For instance, literature
indicates the association of poor quality of locally manufactured antimalarial drugs: Sulfadox-
ine-Pyrimethamine with clinical failure of malaria treatment in Pakistan [43]. Therefore, the
results of the present study and a recent report by Newton and his colleagues [44] point to the
requirement of guidelines for quality assurance of medicines used in clinical trials. Subjects lost
at follow-up per STH species were the limitations of this study.
In conclusion, this study demonstrated that the two investigated brands of ABZ tablets are effi-
cacious against A. lumbricoides and hookworm while both brands had reduced efficacy against T.
trichiura. However, there was a significant difference between the two brands of ABZ against
hookworm.While both brands showed comparable tablet mass uniformity and albendazole con-
tent, the in-vitro dissolution release profile between the two brands was significantly different,
explaining the clinical efficacy difference observed. The results of the present study underscore the
importance of assessing the chemical and physicochemical quality of drugs before conducting effi-
cacy assessment in clinical trials to ensure appropriate therapeutic efficacy and to exclude poor
drug quality as a factor of reduced drug efficacy other than anthelminthic resistance. Our in-vivo
efficacy study clearly indicates the importance of appropriate quality medicines.
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